186 related articles for article (PubMed ID: 38218887)
1. Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect.
Kumar S; Oh JM; Prabhakaran P; Awasti A; Kim H; Mathew B
Sci Rep; 2024 Jan; 14(1):1264. PubMed ID: 38218887
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.
Tripathi RK; Krishnamurthy S; Ayyannan SR
ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797
[TBL] [Abstract][Full Text] [Related]
3. (Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors.
Palakkathondi A; Oh JM; Dev S; Rangarajan TM; Kaipakasseri S; Kavully FS; Gambacorta N; Nicolotti O; Kim H; Mathew B
ACS Comb Sci; 2020 Nov; 22(11):592-599. PubMed ID: 33047950
[TBL] [Abstract][Full Text] [Related]
4. Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease.
Manoharan A; Oh JM; Benny F; Kumar S; Abdelgawad MA; Ghoneim MM; Shaker ME; El-Sherbiny M; Almohaimeed HM; Gahtori P; Kim H; Mathew B
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630420
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
[TBL] [Abstract][Full Text] [Related]
6. Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment.
Benny F; Oh JM; Kumar S; Abdelgawad MA; Ghoneim MM; Abdel-Bakky MS; Kukerti N; Jose J; Kim H; Mathew B
RSC Adv; 2023 Nov; 13(50):35240-35250. PubMed ID: 38053684
[TBL] [Abstract][Full Text] [Related]
7. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
8. Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones.
Singh AK; Kim SM; Oh JM; Abdelgawad MA; Ghoneim MM; Rangarajan TM; Kumar S; Sudevan ST; Trisciuzzi D; Nicolotti O; Kim H; Mathew B
Chem Biol Drug Des; 2023 Aug; 102(2):271-284. PubMed ID: 37011915
[TBL] [Abstract][Full Text] [Related]
9. Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.
Alagöz MA; Oh JM; Zenni YN; Özdemir Z; Abdelgawad MA; Naguib IA; Ghoneim MM; Gambacorta N; Nicolotti O; Kim H; Mathew B
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744926
[TBL] [Abstract][Full Text] [Related]
10. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library.
Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S
Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
[TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase inhibition by selected dye compounds.
de Beer F; Petzer JP; Petzer A
Chem Biol Drug Des; 2020 Mar; 95(3):355-367. PubMed ID: 31834986
[TBL] [Abstract][Full Text] [Related]
13. Docking, Synthesis, and I
Muthukumaran T; Kumar KA; Francis MS
Curr Comput Aided Drug Des; 2024; 20(5):431-440. PubMed ID: 37231754
[TBL] [Abstract][Full Text] [Related]
14. Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases.
Vishnu MS; Pavankumar V; Kumar S; Raja AS
ChemMedChem; 2019 Jul; 14(14):1359-1376. PubMed ID: 31177620
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents.
Kumar B; Kumar M; Dwivedi AR; Kumar V
ChemMedChem; 2018 Apr; 13(7):705-712. PubMed ID: 29534334
[TBL] [Abstract][Full Text] [Related]
17. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H
ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824
[TBL] [Abstract][Full Text] [Related]
18. Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease.
Mathew GE; Oh JM; Mohan K; Tengli A; Mathew B; Kim H
J Biomol Struct Dyn; 2021 Aug; 39(13):4786-4794. PubMed ID: 32588753
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors.
Kumar B; Sheetal ; Mantha AK; Kumar V
Bioorg Chem; 2018 Apr; 77():252-262. PubMed ID: 29421700
[TBL] [Abstract][Full Text] [Related]
20. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
